Analysts at Goldman Sachs reiterated their Buy rating on shares of Medco Health Solutions (MHS), stating that the sell-off in shares was "overdone".
Goldman Sachs will also keep the $76 price target, as they expect "a strong second half running into 2011...more aggressive share buyback assumptions in 2010 and 2011."
Medco Health Solutions, a healthcare company, provides clinically driven pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals in the United States and internationally.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in